Mobilizing Endogenous Progenitor Cells Using pSDF1α‐Activated Scaffolds Accelerates Angiogenesis and Bone Repair in Critical‐Sized Bone Defects
Advanced Healthcare Materials · 2024-09 · 13 (23)
DOI: 10.1002/adhm.202401031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 24.06.2024. Verfasst von Rosanne M Raftery und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Engineering Research Group, Department of Anatomy and Regenerative Medicine, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland. Hauptthemen laut MEDLINE: Neovascularization, Physiologic, Mesenchymal Stem Cells, Tissue Scaffolds, Bone Regeneration. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Higher Education Authority North-South Research Programme, Science Foundation Ireland.
Abstract (Originalsprache)
Mobilizing endogenous progenitor cells to repair damaged tissue in situ has the potential to revolutionize the field of regenerative medicine, while the early establishment of a vascular network will ensure survival of newly generated tissue. In this study, a gene‐activated scaffold containing a stromal derived factor 1α plasmid (pSDF1α), a pro‐angiogenic gene that is also thought to be involved in the recruitment of mesenchymal stromal cells (MSCs) to sites of injury is described. It is shown that over‐expression of SDF1α protein enhanced MSC recruitment and induced vessel‐like structure formation by endothelial cells in vitro. When implanted subcutaneously, transcriptomic analysis reveals that endogenous MSCs are recruited and significant angiogenesis is stimulated. Just 1‐week after implantation into a calvarial critical‐sized bone defect, pSDF1α‐activated scaffolds are recruited MSCs and rapidly activate angiogenic and osteogenic programs, upregulating Runx2 , Dlx5 , and Sp7 . At the same time‐point, pVEGF‐activated scaffolds are recruited a variety of cell types, activating endochondral ossification. The early response induced by both scaffolds leads to complete bridging of the critical‐sized bone defects within 4‐weeks. The versatile cell‐free gene‐activated scaffold described in this study is capable of harnessing and enhancing the body's own regenerative capacity and has immense potential in a myriad of applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tissue Engineering Research Group, Department of Anatomy and Regenerative Medicine, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland.
- Trinity Centre for Biomedical Engineering (TCBE), Trinity College Dublin, Dublin 2, Dublin, D02 PN40, Ireland.
- Advanced Materials and Bioengineering Research Centre (AMBER), RCSI and TCD, Dublin, D02 YN77, Ireland.
- iEd Hub and Department of Anatomy and Neuroscience, College of Medicine and Health, University College Cork, Cork, T12 CY82, Ireland.
- Translational Research in Nanomedical Devices, School of Pharmacy, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland.
- Department of Physiology and Medical Physics, Centre for the Study of Neurological Disorders, Microsurgical Research and Training Facility (MRTF), Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland.
ORCID-Profile: Rosanne M Raftery, Arlyng G Gonzalez Vazquez, David P Walsh, Fergal J O'Brien
Förderung
- Higher Education Authority North-South Research Programme
- Science Foundation Ireland
Zitieren
APA
Raftery, R. M., Gonzalez Vazquez, A. G., Walsh, D. P., Chen, G., Laiva, A. L., Keogh, M. B., & O'Brien, F. J. (2024). Mobilizing Endogenous Progenitor Cells Using pSDF1α‐Activated Scaffolds Accelerates Angiogenesis and Bone Repair in Critical‐Sized Bone Defects. Advanced Healthcare Materials, 13(23). https://doi.org/10.1002/adhm.202401031
Vancouver
Raftery RM, Gonzalez Vazquez AG, Walsh DP, Chen G, Laiva AL, Keogh MB, et al. Mobilizing Endogenous Progenitor Cells Using pSDF1α‐Activated Scaffolds Accelerates Angiogenesis and Bone Repair in Critical‐Sized Bone Defects. Advanced Healthcare Materials. 2024;13(23). doi:10.1002/adhm.202401031
BibTeX
@article{Raftery2024,
author = {Raftery, Rosanne M and Gonzalez Vazquez, Arlyng G and Walsh, David P and Chen, Gang and Laiva, Ashang L and Keogh, Michael B and O'Brien, Fergal J},
title = {Mobilizing Endogenous Progenitor Cells Using pSDF1α‐Activated Scaffolds Accelerates Angiogenesis and Bone Repair in Critical‐Sized Bone Defects},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {23},
doi = {10.1002/adhm.202401031}
}
EUVIMED